메뉴 건너뛰기




Volumn 35, Issue 1, 2002, Pages 12-18

Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: Results of a randomized, double-blind, parallel-group multicenter study

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; IDEBENONE; PLACEBO; TACRINE;

EID: 0036172871     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-19833     Document Type: Article
Times cited : (73)

References (28)
  • 3
    • 4243453896 scopus 로고
    • Empfehlungen zum wirkungsnachweis von nootropika im indikationsbereich "demenz" (Phase III)
    • (1991) Bundesgesundheitsblatt , vol.34 , pp. 342-350
  • 7
    • 0031593616 scopus 로고    scopus 로고
    • Sustained efficacy and safety of idebenone in the treatment of Alzheimer's Disease: Update on a 2-Year Double-Blind Multicentre Study
    • (1998) J Neural Transm , vol.54 , pp. 301-310
    • Gutzmann, H.1    Hadler, D.2
  • 13
    • 0021153537 scopus 로고
    • Practical and valid approach to evaluate the efficacy of nootropic drugs by means of rating scales
    • (1984) Pharmacopsychiatry , pp. 71-75
    • Lehmann, E.1
  • 21
    • 0030967165 scopus 로고    scopus 로고
    • A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study
    • (1997) N Engl J Med , vol.336 , pp. 1216-1222
    • Sano, M.1    Ernesto, C.2    Thomas, R.G.3
  • 28
    • 0008364184 scopus 로고    scopus 로고
    • th World Medical Assembly, Hong Kong, September 1989


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.